...
首页> 外文期刊>Journal of Clinical and Diagnostic Research >Cardiac MR Imaging in the Evaluation of Rheumatic Valvular Heart Diseases
【24h】

Cardiac MR Imaging in the Evaluation of Rheumatic Valvular Heart Diseases

机译:心脏磁共振成像在风湿性心脏瓣膜病的评估中

获取原文

摘要

Introduction: Rheumatic heart disease is the most common cause of valvular heart disease throughout the world. Echocardiography is the dominant imaging investigation in the assessment of cardiac valvular disease and the role of Magnetic Resonance Imaging (MRI) is so far limited. However, due to rapid improvements in the cardiac MRI technology in past few years, this non invasive technique is gaining interest in the examination of cardiac valves. Aim: Our study was undertaken to define the role of MRI in the evaluation of Rheumatic valvular heart disease and to compare the role of MRI with transthoracic echocardiography with regard to quantity of stenosis and volume regurgitation. Materials and Methods: ECG gated Cardiac MRI was performed with a 1.5-Tesla system (MAGNETOM SYMPHONY- Model 2005) using basic cardiac software (Argus viewer) by a phased-array multicoil on 50 subjects who were known cases of Rheumatic valvular heart disease. A chest radiograph and echocardiography were done in all patients before MR examination. Informed consent was taken from all patients. Results: Mitral stenosis either as an isolated valvular abnormality or in combination with other valvular abnormalities constituted the major bulk of Rheumatic valvular heart disease in our study population. The average ejection fraction by ECHO is 64.94±7.11 and by MRI 67.52±7.84. The average mitral valve area by ECHO is 1.79±0.43 cm2 and by MRI 1.82±0.47 cm2. The average aortic valve area by ECHO is 1.10±0.21 cm2 and by MRI 1.12±0.25 cm2. The Coefficient of Correlation (r) is 0.82 for ejection fraction, 0.98 for mitral valve area and 0.92 for aortic valve area which means a strong positive association between the results by ECHO and MRI. In all instances, the p-value is <0.00001, suggesting that the test is highly significant. Conclusion: In our study echocardiography was found to be the gold standard for the diagnosis of Rheumatic valvular heart disease and the role of MRI remained only complimentary to Echocardiography. However with advanced cardiac software, more advanced techniques, and faster imaging sequences, MRI may become a valuable procedure for investigation and follow-up of patients with valvular heart disease.
机译:简介:风湿性心脏病是全世界瓣膜性心脏病的最常见原因。超声心动图是评估心脏瓣膜疾病的主要影像学研究,迄今为止,磁共振成像(MRI)的作用是有限的。但是,由于过去几年中心脏MRI技术的快速改进,这种非侵入性技术引起了对心脏瓣膜检查的关注。目的:我们的研究旨在确定MRI在评估风湿性瓣膜性心脏病中的作用,并比较MRI和经胸超声心动图在狭窄程度和容量反流方面的作用。材料和方法:使用1.5-Tesla系统(MAGNETOM SYMPHONY- Model 2005),使用基本的心脏软件(Argus viewer),通过相控阵多线圈对50名已知为风湿性瓣膜性心脏病的受试者进行ECG门控心脏MRI。在进行MR检查之前,所有患者均进行了胸片和超声心动图检查。所有患者均获得知情同意。结果:二尖瓣狭窄是孤立的瓣膜异常或与其他瓣膜异常的结合,构成了我们研究人群中风湿性瓣膜性心脏病的主要部分。 ECHO的平均射血分数为64.94±7.11,MRI的平均射血分数为67.52±7.84。 ECHO测得的平均二尖瓣面积为1.79±0.43 cm2,MRI测得的平均二尖瓣面积为1.82±0.47 cm2。 ECHO的平均主动脉瓣面积为1.10±0.21 cm2,MRI的平均主动脉瓣面积为1.12±0.25 cm2。射血分数的相关系数(r)为0.82,二尖瓣面积为0.98,主动脉瓣面积为0.92,这意味着ECHO和MRI结果之间存在很强的正相关性。在所有情况下,p值均小于0.00001,表明该检验具有高度显着性。结论:在我们的研究中,超声心动图被认为是诊断风湿性心脏瓣膜病的金标准,而MRI的作用仍然是超声心动图的补充。但是,借助先进的心脏软件,更先进的技术和更快的成像序列,MRI可能成为研究和随访瓣膜性心脏病患者的有价值的程序。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号